previous studies have shown that in thyroparathyroidectomized rats injection of disodium ethane-1-hydroxy-1,1-diphosphonate ( ehdp ) at doses that inhibit bone mineral retention ( 0.16 mmol = 10 mg of phosphorus/kg body wt . per day subcutaneously ) leads to a decrease in the net tubular reabsorption of phosphate .
C0012544
diphosphonate
C0086268
ehdp